Drug information for PRIFTIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
150MG
Prescription
(Reference Drug)
RIFAPENTINE
rifapentine
SANOFI AVENTIS US
21024
2010-08-09 Letter
2010-07-30 Label
2009-06-03 Label
2009-06-02 Letter
2000-10-20 Letter
2000-10-20 Label
2000-10-20 Review
1998-06-22 Letter
1998-06-22 Review
1998-06-22 Label
Drug Adverse Effects information for PRIFTIN
Role code
Indications
Reaction
# Reports
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
ARTHRALGIA
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
CHILLS
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
DIARRHOEA
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
DYSPNOEA
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
HEADACHE
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
INFLUENZA
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
NAUSEA
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
PAIN
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
PYREXIA
2
PS
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
VOMITING
2
Ads by Google